Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Diencephalic syndrome as sign of tumor progression in a child with neurofibromatosis type 1 and optic pathway glioma: a case report.

Cavicchiolo ME, Opocher E, Daverio M, Bendini M, Viscardi E, Bisogno G, Perilongo G, Da Dalt L.

Childs Nerv Syst. 2013 Oct;29(10):1941-5. doi: 10.1007/s00381-013-2109-5. Epub 2013 Apr 25.

PMID:
23615855
2.

Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.

Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, Balcer LJ, Liu GT.

Neuro Oncol. 2012 Jun;14(6):790-7. doi: 10.1093/neuonc/nos076. Epub 2012 Apr 3.

3.

Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.

Dalla Via P, Opocher E, Pinello ML, Calderone M, Viscardi E, Clementi M, Battistella PA, Laverda AM, Da Dalt L, Perilongo G.

Neuro Oncol. 2007 Oct;9(4):430-7. Epub 2007 Aug 17.

4.

High-Dose Intravenous Vitamin C Treatment of a Child with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Case Report.

Mikirova N, Hunnunghake R, Scimeca RC, Chinshaw C, Ali F, Brannon C, Riordan N.

Am J Case Rep. 2016 Oct 24;17:774-781.

5.

Extensive central nervous system involvement in optic pathway gliomas in neurofibromatosis type 1.

Shaikh F, Johnston D, Michaud J, Hurteau J, Vassilyadi M, Keene D.

Pediatr Blood Cancer. 2011 Oct;57(4):688-6690. doi: 10.1002/pbc.23143. Epub 2011 Apr 4.

PMID:
21465640
6.

Natural history and outcome of optic pathway gliomas in children.

Nicolin G, Parkin P, Mabbott D, Hargrave D, Bartels U, Tabori U, Rutka J, Buncic JR, Bouffet E.

Pediatr Blood Cancer. 2009 Dec 15;53(7):1231-7. doi: 10.1002/pbc.22198.

PMID:
19621457
7.

Visual acuity of children treated with chemotherapy for optic pathway gliomas.

Kalin-Hajdu E, Décarie JC, Marzouki M, Carret AS, Ospina LH.

Pediatr Blood Cancer. 2014 Feb;61(2):223-7. doi: 10.1002/pbc.24726. Epub 2013 Aug 19.

PMID:
23956233
8.

Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome.

King A, Listernick R, Charrow J, Piersall L, Gutmann DH.

Am J Med Genet A. 2003 Oct 1;122A(2):95-9.

PMID:
12955759
9.

Rare case of optic pathway glioma with extensive intra-ocular involvement in a child with neurofibromatosis type 1.

Gupta V, Sabri K, Whelan KF, Viscardi V.

Middle East Afr J Ophthalmol. 2015 Jan-Mar;22(1):117-8. doi: 10.4103/0974-9233.148361.

10.

Optic glioma warranting treatment in children.

Kaufman LM, Doroftei O.

Eye (Lond). 2006 Oct;20(10):1149-64.

PMID:
17019413
11.

Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.

Kuenzle C, Weissert M, Roulet E, Bode H, Schefer S, Huisman T, Landau K, Boltshauser E.

Neuropediatrics. 1994 Dec;25(6):295-300.

PMID:
7770126
12.

Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy.

Silva MM, Goldman S, Keating G, Marymont MA, Kalapurakal J, Tomita T.

Pediatr Neurosurg. 2000 Sep;33(3):151-8.

PMID:
11096362
13.

Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.

Segal L, Darvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC.

J AAPOS. 2010 Apr;14(2):155-8. doi: 10.1016/j.jaapos.2009.11.020.

PMID:
20451859
14.

Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.

Thiagalingam S, Flaherty M, Billson F, North K.

Ophthalmology. 2004 Mar;111(3):568-77. Review.

PMID:
15019338
16.

Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort.

Blanchard G, Lafforgue MP, Lion-François L, Kemlin I, Rodriguez D, Castelnau P, Carneiro M, Meyer P, Rivier F, Barbarot S, Chaix Y; NF France network..

Eur J Paediatr Neurol. 2016 Mar;20(2):275-81. doi: 10.1016/j.ejpn.2015.12.002. Epub 2015 Dec 17.

PMID:
26774135
17.

Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.

Listernick R, Ferner RE, Liu GT, Gutmann DH.

Ann Neurol. 2007 Mar;61(3):189-98. Review.

PMID:
17387725
18.

Diencephalic syndrome: a frequently delayed diagnosis in failure to thrive.

Huber J, Sovinz P, Lackner H, Mokry M, Eder H, Urban C.

Klin Padiatr. 2007 Mar-Apr;219(2):91-4.

PMID:
17405074
20.

Optic glioma and precocious puberty in a girl with neurofibromatosis type 1 carrying an R681X mutation of NF1: case report and review of the literature.

Kocova M, Kochova E, Sukarova-Angelovska E.

BMC Endocr Disord. 2015 Dec 15;15:82. doi: 10.1186/s12902-015-0076-4. Review.

Supplemental Content

Support Center